"For the triumph of evil it is only necessary for good men to do nothing." Edmund Burke
 
Top News arrow Safety Issues arrow Public Policy
Safety Issues - Public Policy
Why Eli Lilly's Alzheimer's Imaging Test- Amyvid- Is NO Breakthrough Print E-mail
Wednesday, 11 April 2012
On Friday, April 6, the FDA approved another of Eli Lilly's "breakthroughs" whose clinical value is questionable (at best). 
Read more...
 
Gene Mutation Risk for Autism --5% to 20% Print E-mail
Friday, 06 April 2012

The Centers for Disease Control issued an alarming report: 1 in 88 US children are afflicted with autism--an increase of 25% between 2006-2008.

Read more...
 
9 Medical Specialties Recommend Reducing 45 Tests Print E-mail
Thursday, 05 April 2012

“Overuse is one of the most serious crises in American medicine.” The crisis is not only of misspending of resources, overuse of medical treatments is causing  treatment-produced harm, including preventable deaths. 

Read more...
 
Cancer Research False Claims Print E-mail
Thursday, 29 March 2012
100 Amgen scientists were astonished to find that they were able to replicate the results of only 6 of 53 widely cited landmark cancer research papers. 
Read more...
 
High Court Exonerates Senior Author of Controversial MMR Paper Print E-mail
Thursday, 08 March 2012
The UK High Court issued a ruling completely exonerating Dr. John Walker-Smith, co-author of the maligned vaccine article published by The Lancet in 1998.
Read more...
 
More...
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 64 - 72 of 796
[ Back ]
(C) 2013 Alliance for Human Research Protection

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]